Europe, not the US, is the first to authorize Moderna’s mRNA flu-COVID combination vaccine

Moderna’s mRNA-based combination flu and COVID-19 vaccine has been given the green light in Europe but remains shelved in the United States, where it was developed. This week, the European Commission authorized Moderna to market the vaccine, mRNA-1083 or mCOMBRIAX,…













